Celiac disease diagnosis in clinical practice: ESPGHAN quality of care survey from 129 pediatric hospitals across 28 countries
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
ESPGHAN
Ludwig Maximilians Universität Munich
PubMed
40621676
PubMed Central
PMC12408967
DOI
10.1002/jpn3.70143
Knihovny.cz E-zdroje
- Klíčová slova
- children, guidelines, histopathology, potential celiac disease, transglutaminase antibodies,
- MeSH
- autoprotilátky krev MeSH
- celiakie * diagnóza krev MeSH
- dětské nemocnice MeSH
- dítě MeSH
- gastroenterologie normy MeSH
- imunoglobulin A krev MeSH
- kvalita zdravotní péče * MeSH
- lékařská praxe - způsoby provádění * statistika a číselné údaje MeSH
- lidé MeSH
- průzkumy a dotazníky MeSH
- průzkumy zdravotní péče MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- transglutaminasy imunologie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
- Názvy látek
- autoprotilátky MeSH
- imunoglobulin A MeSH
- transglutaminasy MeSH
OBJECTIVES: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) guidelines recommend first-line serology for suspected celiac disease (CeD), measuring only transglutaminase antibodies (TGA-immunoglobulin A [IgA]) plus total IgA. If TGA-IgA is ≥10 times the normal value, pediatric gastroenterologists (pedGI) may diagnose CeD without biopsies if autoantibodies against endomysial antibodies (EMA-IgA) are positive in a 2nd blood sample. This Quality-of-Care (QoC) project benchmarked diagnostic workup in clinical practice using ESPGHAN CeD guidelines as reference. METHODS: A pseudonymized survey on CeD practices was sent to 141 hospitals within the ESPGHAN QoC-network in 28 countries. RESULTS: Questionnaires were completed by 129/141 (91.5%) hospitals, with 121 (94%) having pedGI staff. As reasons conflicting with good QoC for CeD in their setting, responders assumed knowledge deficits among the public (57%), primary care providers (64%), non-GI physicians (16%), and pedGIs (0%). For initial testing, 66% of physicians ordered only total IgA and TGA-IgA, 7% did not use this combination, and 29% ordered additional serology (TGA-IgG, EMA, antibodies against deaminated gliadin peptide, or native gliadin). Regarding conflicting results for TGA-IgA and histopathology in IgA-sufficient children, 61% incorrectly classified negative TGA-IgA with Marsh 2 and 57% with Marsh 3 lesions as "potential CeD," while 49% excluded CeD in the case of villous atrophy and negative TGA-IgA. Routine practice did not align with the ESPGHAN recommendations regarding performance of duodenal biopsies (27%), EMA-testing (34%), and diagnosis of CeD in IgA-deficient children (32%). CONCLUSIONS: We identified areas for improving QoC regarding both effectiveness and efficacy, in pediatric patients with suspected CeD, and consequently developed easy-to-use tools to improve guideline implementation.
Central Lisbon University Hospital Centre Lisbon Portugal
The European Society for Paediatric Gastroenterology Hepatology and Nutrition Geneva Switzerland
Unit of Nutrition and Obesity Hospital Recoletas Campo Grande Valladolid Spain
Zobrazit více v PubMed
Husby S, Koletzko S, Korponay‐Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136‐160. PubMed
Husby S, Koletzko S, Korponay‐Szabó I, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141‐156. PubMed
Werkstetter KJ, Korponay‐Szabó IR, Popp A, et al. Accuracy in diagnosis of celiac disease without biopsies in clinical practice. Gastroenterology. 2017;153(4):924‐935. PubMed
Arguelles‐Grande C, Tennyson CA, Lewis SK, Green PHR, Bhagat G. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol. 2012;65(3):242‐247. PubMed
Mubarak A, Nikkels P, Houwen R, Ten Kate F. Reproducibility of the histological diagnosis of celiac disease. Scand J Gastroenterol. 2011;46(9):1065‐1073. PubMed
Popp A, Arvola T, Taavela J, et al. Nonbiopsy approach for celiac disease is accurate when using exact duodenal histomorphometry: prospective study in 2 countries. J Clin Gastroenterol. 2021;55(3):227‐232. PubMed
Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43‐52. PubMed PMC
Litwin A, Le Thi TG, Pancheva R, et al. Anthropometric assessment: ESPGHAN quality of care survey from paediatric hospitals in 28 European countries. J Pediatr Gastroenterol Nutr. 2024;78(4):936‐947. PubMed
Lacaille F, Nicastro E, Czubkowski P, et al. Awareness, referral and age at Kasai surgery for biliary atresia in Europe: a survey of the Quality‐of‐Care Task Force of ESPGHAN. J Pediatr Gastroenterol Nutr. 2024;78(6):1374‐1382. PubMed
Riznik P, De Leo L, Dolinsek J, et al. The knowledge about celiac disease among healthcare professionals and patients in central Europe. J Pediatr Gastroenterol Nutr. 2021;72(4):552‐557. PubMed
Khalil H, de Moel‐Mandel C, Verma D, et al. Characteristics of quality improvement projects in health services: a systematic scoping review. J Evid Based Med. 2025;18(1):e12670. PubMed PMC
Gould MJ, Brill H, Marcon MA, Munn NJ, Walsh CM. In screening for celiac disease, deamidated gliadin rarely predicts disease when tissue transglutaminase is normal. J Pediatr Gastroenterol Nutr. 2019;68(1):20‐25. PubMed
Dios A, Srinivasan B, Gyimesi J, et al. Changes in non‐deamidated versus deamidated epitope targeting and disease prediction during the antibody response to gliadin and transglutaminase of infants at risk for celiac disease. Int J Mol Sci. 2022;23(5):2498. PubMed PMC
Popp A, Laurikka P, Czika D, Kurppa K. The role of gluten challenge in the diagnosis of celiac disease: a review. Expert Rev Gastroenterol Hepatol. 2023;17(7):691‐700. PubMed
Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta‐analysis. Am J Gastroenterol. 2017;112(1):65‐76. PubMed
Rosén A, Sandström O, Carlsson A, et al. Usefulness of symptoms to screen for celiac disease. Pediatrics. 2014;133(2):211‐218. PubMed
Agardh D, Lee HS, Kurppa K, et al. Clinical features of celiac disease: a prospective birth cohort. Pediatrics. 2015;135(4):627‐634. PubMed PMC
Egner W, Shrimpton A, Sargur R, Patel D, Swallow K. ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres. J Pediatr Gastroenterol Nutr. 2012;55(6):733‐735. PubMed
Backhouse A, Ogunlayi F. Quality improvement into practice. BMJ. 2020;368:m865. PubMed PMC